CD19 and B-cell non-Hodgkin lymphoma: Another retrospective study in patients with R/R large B-cell lymphoma similarly identified predictors of early CD19 CART failure, which included the presence of either bulky lesions (defined as ≥5 cm in diameter) or necrotic tissue in tumor lesions (6).